Hospira irinotecan hydrochloride trihydrate IV Infusion 100 mg

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL

Saadav alates:

Hospira Australia Pty Ltd

INN (Rahvusvaheline Nimetus):

irinotecan hydrochloride trihydrate

Ravimvorm:

Injection, intravenous infusion

Koostis:

Excipient Ingredients: lactic acid; sorbitol; water for injections

Manustamisviis:

Intravenous Infusion

Ühikuid pakis:

1 x 5 mL vial

Klass:

Medicine Listed (Export Only)

Retsepti tüüp:

(S1) This Schedule is intentionally blank

Näidustused:

Small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non Hodgkin's disease).

Toote kokkuvõte:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2013-01-31